Svetlin Georgiev Georgiev

Mr. Svetlin Georgiev Georgiev


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Advances in the Theory of Nonlinear Analysis and its Application
Verified
Journal Article
Open access
SBSalim Bensli̇mAne
Salim Bensli̇mAne
SGSvetlin Georgiev Georgiev
Svetlin Georgiev Georgiev
KMKarima MEBARKI
Karima MEBARKI
In this paper, we study a class of fourth-order boundary value problems with integral boundary conditions. The nonlinearity may have time-singularity and change sign. Moreover, it satisfies general polynomial growth conditions. A new topological approach is applied to prove the existence of at least two nonnegative classical solutions. An example of application illustrates the existence result.

2 May 2024 in Proyecciones (Antofagasta)
Verified
Journal Article
Open access
PDF file
LBLydia Bouchal
Lydia Bouchal
KMKarima Mebarki
Karima Mebarki
SGSvetlin Georgiev Georgiev
Svetlin Georgiev Georgiev
This paper discusses the existence of solutions to fourth order nonlinear boundary value problem involving systems of differential equations and two point boundary conditions. The nonlinearity f ∈ C ([0,1] × Rn+ × Rn × Rn × Rn, Rn)considered in this paper includes derivatives up to order three. Using recent fixed point results for the sum of two operators, we impose a growth condition on f to establish a new existence criteria that ensure the existence of at least one and the existence of at least two nonnegative solutions.

2 August 2017 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
SGSvetlin Georgiev Georgiev
Svetlin Georgiev Georgiev
AYAntoniya Yordanova Yanakieva
Antoniya Yordanova Yanakieva
SPStamatios Priftis
Stamatios Priftis
Background: Broadly defined, health technology assessment (HTA) is the systematic evaluation of medical technologies. This approach takes in to account effectiveness of the technologies, social and ethical aspects and efficiency as well as. A large number of countries globally have not yet implemented the use of HTA because of varying reasons. \ud Purpose: The study aims to show the correlation between the presence of official HTA body and the socioeconomic features. \ud Material/Methods: In a 3-month period we used the method of document analysis from different sources regarding the presence of HTA bodies all over the world. A process for verification of the information used was developed and implemented. The same process was used to derive the presented information from the analysis. \ud Results: About one in two countries have formal HTA process to inform decision making, in which they systematically collect data and consider the impacts of a particular health technology or intervention. However, almost а quarter of the studied countries are located in Europe, most of them (86%) have an official HTA agency that operates in the country. We found that 80% of HTA bodies all over the World are located in countries with high income rate and most of them are European.\ud Conclusions It was found that it is possible to establish a correlation between the socio-economic parameters of a country and the existence of an active HTA agency in it

27 November 2025 in Pharmacia
Verified
Journal Article
Open access
PDF file
SGSvetlin Georgiev Georgiev
Svetlin Georgiev Georgiev
Borislav BorissovBorislav Borissov
Borislav Borissov
AVAlexandrina Vodenicharova
Alexandrina Vodenicharova
AYAntoniya Yordanova Yanakieva
Antoniya Yordanova Yanakieva
Bulgaria is assumed to be the country with the lowest COVID-19 vaccination coverage in the EU. The present study aims to highlight the economic impact of vaccine hesitancy. The period analyzed is from 1 January 2021 to 31 December 2021, examining hospitalization costs for COVID-19 patients, vaccine application costs, and vaccine type and dose administered. Results demonstrate a net impact of BGN 97 686 089 (€49 946 104) if 30% of the eligible population had been vaccinated and BGN 146 529 133 (€74 919 156) if a 45% rate had been achieved. In addition, 5.1 million unused doses were scrapped—more than those administered. The public health impact of vaccine hesitancy in Bulgaria led to a preventable medical crisis, substantial economic losses due to avoidable hospitalizations, and significant additional costs associated with the destruction of unused vaccines.

3 May 2021
Verified
Book Chapter
Closed access
PDF file
SGSvetlin Georgiev Georgiev
Svetlin Georgiev Georgiev

3 May 2021
Verified
Book Chapter
Closed access
PDF file
SGSvetlin Georgiev Georgiev
Svetlin Georgiev Georgiev